Histological regression of giant cell tumor of bone following RANK ligand inhibition

Martin F. Dietrich; Dominick Cavuoti; Michael Landay; Yull E. Arriaga

doi:10.1177/2324709614560216

Histological regression of giant cell tumor of bone following RANK ligand inhibition

Martin F. Dietrich, Dominick Cavuoti, Michael Landay, Yull E. Arriaga

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

Original language	English (US)
Journal	Journal of Investigative Medicine High Impact Case Reports
Volume	2
Issue number	4
DOIs	https://doi.org/10.1177/2324709614560216
State	Published - Nov 14 2014

Keywords

Denosumab
Giant cell tumor
Lung metastases
RANK ligand

ASJC Scopus subject areas

Epidemiology
Safety, Risk, Reliability and Quality
Safety Research

Access to Document

10.1177/2324709614560216

Cite this

@article{2b7cd47b487b49e390a0c6059344bbd3,

title = "Histological regression of giant cell tumor of bone following RANK ligand inhibition",

abstract = "Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.",

keywords = "Denosumab, Giant cell tumor, Lung metastases, RANK ligand",

author = "Dietrich, {Martin F.} and Dominick Cavuoti and Michael Landay and Arriaga, {Yull E.}",

note = "Publisher Copyright: {\textcopyright} 2014 American Federation for Medical Research.",

year = "2014",

month = nov,

day = "14",

doi = "10.1177/2324709614560216",

language = "English (US)",

volume = "2",

journal = "Journal of Investigative Medicine High Impact Case Reports",

issn = "2324-7096",

publisher = "Sage Publications",

number = "4",

}

TY - JOUR

T1 - Histological regression of giant cell tumor of bone following RANK ligand inhibition

AU - Dietrich, Martin F.

AU - Cavuoti, Dominick

AU - Landay, Michael

AU - Arriaga, Yull E.

PY - 2014/11/14

Y1 - 2014/11/14

N2 - Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

AB - Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

KW - Denosumab

KW - Giant cell tumor

KW - Lung metastases

KW - RANK ligand

UR - http://www.scopus.com/inward/record.url?scp=85012135732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012135732&partnerID=8YFLogxK

U2 - 10.1177/2324709614560216

DO - 10.1177/2324709614560216

M3 - Article

C2 - 26425630

AN - SCOPUS:85012135732

SN - 2324-7096

VL - 2

JO - Journal of Investigative Medicine High Impact Case Reports

JF - Journal of Investigative Medicine High Impact Case Reports

IS - 4

ER -

Histological regression of giant cell tumor of bone following RANK ligand inhibition

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this